AVANT Immunotherapeutics Inc. (Nasdaq: AVAN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AVANT Immunotherapeutics Inc. (Nasdaq: AVAN)

AVAN 10.04

0.0%

Jun 12 9:41 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: SemiBull who wrote (452)	4/29/2003 7:29:38 PM
From: tuck	Read Replies (1) of 513

>>Hard to imagine AVAN getting much mileage out of this:... Is that a short, intermediate or long term perspective?<< All of the above. I don't expect the news to affect it one way or the other (it already got punished a year ago), unless they continue to throw money at the program. Discussing licensing is probably a waste of time, but a cheap one, at least. If AVAN has value, it is elsewhere, IMO. What's your take? Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next